Xtx Topco LTD Chimerix Inc Transaction History

Xtx Topco LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.91 - $1.26 $42,788 - $59,245	-47,020 Reduced 56.7%	35,907 $38,000
Q4 2023 Feb 13, 2024	BUY	$0.9 - $1.06 $7,636 - $8,994	8,485 Added 11.4%	82,927 $79,000
Q3 2023 Nov 13, 2023	SELL	$0.94 - $1.23 $227,339 - $297,476	-241,851 Reduced 76.46%	74,442 $71,000
Q2 2023 Aug 14, 2023	BUY	$1.1 - $1.54 $91,246 - $127,744	82,951 Added 35.55%	316,293 $382,000
Q1 2023 May 12, 2023	BUY	$1.19 - $2.09 $110,033 - $193,251	92,465 Added 65.64%	233,342 $294,000
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.35 $72,745 - $102,366	43,560 Added 44.76%	140,877 $262,000
Q3 2022 Nov 14, 2022	BUY	$1.81 - $2.76 $109,009 - $166,223	60,226 Added 162.37%	97,317 $188,000
Q2 2022 Aug 15, 2022	BUY	$1.34 - $5.34 $49,701 - $198,065	37,091 New	37,091 $77,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.